Kazumasa Oya

26PUBLICATIONS
15CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMedical virologyAllergyPeriodonticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 02, 2025
Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment.

Kazumasa Oya, Yoshiyuki Ishii, Keisuke Anju

|Apr 20, 2024
Milia-like appearance of vulvar syringoma.

Shiori Yasunaga, Kazumasa Oya, Yoshiyuki Ishii

|Apr 17, 2024
COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.

Kazumasa Oya, Yoshiyuki Ishii, Shigehiko Takeyama

|Apr 05, 2024
Perforating collagenosis.

Kazumasa Oya, Aki Saito

|Mar 04, 2024
Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.

Kazumasa Oya, Yoshiyuki Nakamura, Larina Tzu-Wei Shen

|Feb 07, 2024
Pemphigoid without mucous involvement showing IgG antibodies to the β3 subunit of laminin-332.

Hanako Miyahara, Kazumasa Oya, Noriko Kubota

Pageof 5